6-31412040-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001177519.3(MICA):​c.707T>C​(p.Ile236Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.456 in 1,601,904 control chromosomes in the GnomAD database, including 177,143 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.54 ( 23270 hom., cov: 31)
Exomes 𝑓: 0.45 ( 153873 hom. )

Consequence

MICA
NM_001177519.3 missense

Scores

15

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.827

Publications

27 publications found
Variant links:
Genes affected
MICA (HGNC:7090): (MHC class I polypeptide-related sequence A) This gene encodes the highly polymorphic major histocompatability complex class I chain-related protein A. The protein product is expressed on the cell surface, although unlike canonical class I molecules it does not seem to associate with beta-2-microglobulin. It is a ligand for the NKG2-D type II integral membrane protein receptor. The protein functions as a stress-induced antigen that is broadly recognized by intestinal epithelial gamma delta T cells. Variations in this gene have been associated with susceptibility to psoriasis 1 and psoriatic arthritis, and the shedding of MICA-related antibodies and ligands is involved in the progression from monoclonal gammopathy of undetermined significance to multiple myeloma. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.5553937E-6).
BP6
Variant 6-31412040-T-C is Benign according to our data. Variant chr6-31412040-T-C is described in ClinVar as Benign. ClinVar VariationId is 403084.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.685 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MICANM_001177519.3 linkc.707T>C p.Ile236Thr missense_variant Exon 4 of 6 ENST00000449934.7 NP_001170990.1 Q96QC4
MICANM_001289152.2 linkc.416T>C p.Ile139Thr missense_variant Exon 4 of 6 NP_001276081.1 Q96QC4A0A024RCL3
MICANM_001289153.2 linkc.416T>C p.Ile139Thr missense_variant Exon 4 of 6 NP_001276082.1 Q96QC4A0A024RCL3
MICANM_001289154.2 linkc.293T>C p.Ile98Thr missense_variant Exon 4 of 6 NP_001276083.1 Q96QC4A0A0G2JJ55

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MICAENST00000449934.7 linkc.707T>C p.Ile236Thr missense_variant Exon 4 of 6 1 NM_001177519.3 ENSP00000413079.1 Q96QC4

Frequencies

GnomAD3 genomes
AF:
0.538
AC:
81544
AN:
151448
Hom.:
23229
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.692
Gnomad AMI
AF:
0.512
Gnomad AMR
AF:
0.609
Gnomad ASJ
AF:
0.678
Gnomad EAS
AF:
0.438
Gnomad SAS
AF:
0.583
Gnomad FIN
AF:
0.450
Gnomad MID
AF:
0.672
Gnomad NFE
AF:
0.438
Gnomad OTH
AF:
0.614
GnomAD2 exomes
AF:
0.492
AC:
108599
AN:
220848
AF XY:
0.492
show subpopulations
Gnomad AFR exome
AF:
0.695
Gnomad AMR exome
AF:
0.604
Gnomad ASJ exome
AF:
0.693
Gnomad EAS exome
AF:
0.422
Gnomad FIN exome
AF:
0.409
Gnomad NFE exome
AF:
0.419
Gnomad OTH exome
AF:
0.525
GnomAD4 exome
AF:
0.448
AC:
649164
AN:
1450338
Hom.:
153873
Cov.:
65
AF XY:
0.452
AC XY:
325969
AN XY:
720744
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.712
AC:
23654
AN:
33234
American (AMR)
AF:
0.625
AC:
26975
AN:
43158
Ashkenazi Jewish (ASJ)
AF:
0.675
AC:
17251
AN:
25554
East Asian (EAS)
AF:
0.507
AC:
20086
AN:
39588
South Asian (SAS)
AF:
0.579
AC:
49065
AN:
84760
European-Finnish (FIN)
AF:
0.429
AC:
22625
AN:
52722
Middle Eastern (MID)
AF:
0.690
AC:
3938
AN:
5706
European-Non Finnish (NFE)
AF:
0.413
AC:
456546
AN:
1105680
Other (OTH)
AF:
0.484
AC:
29024
AN:
59936
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.395
Heterozygous variant carriers
0
16930
33860
50790
67720
84650
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14082
28164
42246
56328
70410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.539
AC:
81636
AN:
151566
Hom.:
23270
Cov.:
31
AF XY:
0.542
AC XY:
40160
AN XY:
74108
show subpopulations
African (AFR)
AF:
0.692
AC:
28538
AN:
41232
American (AMR)
AF:
0.610
AC:
9256
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.678
AC:
2347
AN:
3464
East Asian (EAS)
AF:
0.439
AC:
2247
AN:
5120
South Asian (SAS)
AF:
0.584
AC:
2805
AN:
4806
European-Finnish (FIN)
AF:
0.450
AC:
4756
AN:
10564
Middle Eastern (MID)
AF:
0.664
AC:
194
AN:
292
European-Non Finnish (NFE)
AF:
0.438
AC:
29738
AN:
67890
Other (OTH)
AF:
0.613
AC:
1291
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1847
3694
5542
7389
9236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.417
Hom.:
2152
Bravo
AF:
0.558
ExAC
AF:
0.490
AC:
59138

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
1.1
DANN
Benign
0.41
DEOGEN2
Benign
0.0030
.;.;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.00035
N
MetaRNN
Benign
0.0000036
T;T;T
MetaSVM
Benign
-0.95
T
PhyloP100
-0.83
PrimateAI
Benign
0.33
T
PROVEAN
Benign
2.4
.;N;N
REVEL
Benign
0.033
Sift
Benign
1.0
.;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.034
MPC
0.13
ClinPred
0.0015
T
GERP RS
-2.4
gMVP
0.076
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1140700; hg19: chr6-31379817; COSMIC: COSV69826354; API